Navigation Links
A warmer future for watersports
Date:5/19/2010

effects.

The tests mean Spartan will be able to make better wetsuits more efficiently, meaning a positive impact on a UK company's ability to compete in a crowded global market.

Mark Minter of Spartan said: "NPL's wetsuit testing really helped understand the technical side of wetsuit design. We are now focused on using the correct materials and fully testing everything before production. Neoprene suppliers send samples with claims as to a material's suitability, rather than objective data about thermal performance. NPL's testing highlighted the need to research the correct material. It has saved us producing whole ranges of suits that would be next to useless for the colder northern European countries we sell to, saving us at least 100,000."

In the longer term the techniques developed could have a huge social impact if this work is extended to other wetsuit manufacturers and neoprene suppliers. Richard Dudley of NPL concludes "millions of people in colder European countries such as the UK take part in activities that require wetsuits, from Scuba diving and Triathlons to Surfing and Windsurfing, to brave chilly waters. Improved materials and construction will mean they can spend more time in the water, and enjoy their sport of choice in much colder conditions than they are currently comfortable doing. This will have an important economic benefit for both wetsuit manufacturers and the watersports industry as a whole."


'/>"/>

Contact: David Lewis
david@proofcommunication.com
44-845-680-1865
National Physical Laboratory
Source:Eurekalert

Page: 1 2

Related biology technology :

1. Future Role of Market Research Made Clear in New Report from Best Practices, LLC
2. Is there a micro-supercapacitor in your future?
3. Reportlinker Adds Future of Red Biotechnology in China
4. Association for Environmental Health & Sciences Foundation and Adventus Group Recognize Future Environmental Science Leaders
5. Gloabl Harvest Initiative: Taking Down Fences To Meet Future Needs
6. New graphene nanomesh could change the future of electronics
7. Reportlinker Adds The Future of Nutrigenomics: New opportunities in personalized nutrition and food-pharma collaboration
8. Single-step technique produces both p-type and n-type doping for future graphene devices
9. What's Next for Stevia? Experts from GLG Life Tech Corp Share Views on Stevia's Future at Complimentary Webinar on 17 Feb.
10. InfoSpi Shall Benefit From Contract for Future Use of IBS Technology
11. Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... ... September 01, 2015 , ... In her thought provoking debut novel ‘ Ebola ... not-so-distant future faced with an Ebola pandemic that is on the cusp of wiping ... enter the world of counterterrorism, and who continues to appear in this series of ...
(Date:9/1/2015)... ... 01, 2015 , ... VetStem Biopharma announces new Clinical Research ... problems can be caused by injuries and abnormalities of the cervical spine. Arthritic ... of the spinal cord itself. This can manifest itself as any or all ...
(Date:9/1/2015)... ... September 01, 2015 , ... Leading CEOs, CSOs, CMOs, and ... space join prominent academics and key investors for Neuro Advance Boston, October 14, ... Boston. , Neuro Advance Boston focuses on the latest developments and opportunities ...
(Date:9/1/2015)... , Sept. 1, 2015   Medfusion, ... facilitating the relationship between doctors and patients, today ... Durham, N.C. -based venture capital firms. ... and business association with Bull City Venture Partners ... , Medfusion Founder and Executive Chairman. "Both firms, ...
Breaking Biology Technology:Alexi Venice’s Debut Novel Takes on the Human Testing of a Vaccine for Ebola and Revenge by an Anti-Big Pharma Terrorist Group in ‘Ebola Vaccine Wars' 2Alexi Venice’s Debut Novel Takes on the Human Testing of a Vaccine for Ebola and Revenge by an Anti-Big Pharma Terrorist Group in ‘Ebola Vaccine Wars' 3VetStem Biopharma Announces New Clinical Research Program for Equine Cervical Facet Joint Disease 2VetStem Biopharma Announces New Clinical Research Program for Equine Cervical Facet Joint Disease 3Neuro Advance Boston Brings Together Leading Neuroscience Experts on October 14 at Harvard Medical School 2Medfusion Secures Funding to Continue Evolution and Advance Mobile Strategy 2Medfusion Secures Funding to Continue Evolution and Advance Mobile Strategy 3
... THE WOODLANDS, Texas, June 17 Berlin Heart ... Development Grant by the FDA,to support the ongoing Investigational ... Device (VAD). Dr. Christopher Almond of,the Children,s Hospital of ... Berlin Heart Inc. will serve as Co-Principal,Investigators for the ...
... will accelerate access to improved TB diagnostics , ... Company; NYSE: BDX ), a leading global ... Diagnostics), a Swiss foundation that develops, evaluates and accelerates ... today announced a significant price reduction in the cost ...
... OSLO, Norway, June 17 , ... Remission Rates and,Reduce Short-Term Mortality Compared to Previous Treatments ... CLAVIS) today announces positive final results,from a Phase II ... patients with late-stage acute myeloid leukaemia (AML). In the,trial, ...
Cached Biology Technology:Berlin Heart Inc. Receives FDA Orphan Product Development Grant 2BD and FIND Achieve Milestone in Global Battle Against MDR-TB 2BD and FIND Achieve Milestone in Global Battle Against MDR-TB 3BD and FIND Achieve Milestone in Global Battle Against MDR-TB 4Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late-Stage Leukaemia 2Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late-Stage Leukaemia 3Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late-Stage Leukaemia 4Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late-Stage Leukaemia 5Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late-Stage Leukaemia 6Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late-Stage Leukaemia 7
(Date:8/18/2015)... 18, 2015  Navitas today announced that ... the Submission Content Management webinar scheduled on ... forum. Dedicated to the Implementation of Regulatory Submission ... for industry, vendors, health authorities, consultants and ... towards a standard method of implementing electronic ...
(Date:8/12/2015)... Aug. 12, 2015   MedNet Solutions , an ... spectrum of clinical research, is proud to announce that ... comprehensive SaaS-based eClinical technology platform, has led the way ... two quarters of 2015.   Q2 2015 and Q1 ... measured by contract value sold in the company,s 15 ...
(Date:8/12/2015)... , Aug. 12, 2015  Synaptics Inc. ... human interface solutions, today announced that four of ... Match-in-Sensor solution, have officially been named FIDO Certified™ ... part of the certification, Synaptics, Natural ID™ fingerprint ... Universal Authentication Framework (UAF) standard and are interoperable ...
Breaking Biology News(10 mins):Navitas, a Key Contributor in IRISS Forum Webinar 2Navitas, a Key Contributor in IRISS Forum Webinar 3MedNet Solutions Experiences Explosive Corporate Growth 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 3
... at MIT recently found an elegant solution to a ... doesn,t soak into soil at an even rate, but ... downward. Scientists call these rivulets "gravity fingers," ... with the surface tension where the wateror any liquidmeets ...
... playing a major role in a 4m European project to ... animal feed. Professor Chris Elliott, Director of the Institute ... team of scientists in developing new tests aimed to protect ... of foods including meat, poultry, milk, seafood and cereals. ...
... thousands of families is helping prospective parents work out whether ... work by Corry Gellatly, a research scientist at the university, ... sons or more daughters from their parents. This means that ... sons, while a man with many sisters is more likely ...
Cached Biology News:MIT researchers explain mystery of gravity fingers 2Queen's University Belfast plays leading role in Europe-wide tests for safer food 2Boy or girl? It's in the father's genes 2Boy or girl? It's in the father's genes 3
Mixing speed from 750-3200RPM, small vortexing orbit of1.0mm...
... ,MOLECULAR BIOLOGY GRADE ,5-Bromo-4-chloro-3-indoxyl-beta-D-galactopyranoside C 14 ... N O 6 ,M.W.= 408.63 ... Clear (2% in DMF) ,Biological Activity: ... M13 ,Elemental Analysis: Agrees with theoretical ...
... new D-LUX Detection Platform combines robust ... the most sensitive, specific, and cost-effective ... D-LUX Detection Platform offers exceptional performance ... TaqMan probes, high signal/background ratio, and ...
Based on Silica membrane matrix beads. The kit is designed for the purification of DNA (20 bp - 100 bp) from TAE/TBE agarose gels. Run time is approximately 45 minutes....
Biology Products: